PhotoMedex Helps Clinics Ensure Positive Patient Experience With New XTRAC(R) Laser Post-Procedure Kit

The XTRAC Laser Post-Procedure Kit features PhotoMedex' proven GHK Copper Peptide Complex(R), a therapeutic breakthrough that has been shown to enhance the healing outcome of cosmetic surgery and hair transplant procedures by positively impacting collagen deposition, tensile strength, anglogenesis and SOD activity (data on file). Specific products in the kit include:

-- Complex Cu3(R) Intensive Tissue Repair Creme--Combines patented copper peptide skin health technology in a soothing base formulation for enhanced healing after microdermabrasion, laser resurfacing, chemical peels, dermabrasion and hair removal. Helps eliminate crusting and scabbing, relieves itching and tightness, maintains optimal skin hydration and promotes optimal healing environment.

-- Complex Cu3(R) Post-Laser Lotion--Step-down option from Complex Cu3(R) Intensive Tissue Repair Creme. This lightweight moisturizing lotion provides skin with copper micronutrition and soothes and protects tender skin by helping retain moisture. Ideal under camouflage makeup, this lotion can also be used after chemical peels and dermabrasion.

-- Ti-Silc(R) Sheer SPF 45--A water resistant sunblock that provides protection from the sun's harmful rays while moisturizing the skin. Ti-Silc(R) Sheer contains safety coated micronized titanium dioxide which provides a physical block against UV radiation. Ideal for post-laser and post-procedure sun protection, this sweat-proof product is perfect for outdoor enthusiasts.

"Clinics that perform XTRAC laser treatments have a clear interest in ensuring the best possible outcome for their patients. Our XTRAC Laser Post-Procedure Kit is a powerful new step in that process," said Jeff O'Donnell, President & CEO of PhotoMedex. "Patients undergoing laser treatments or non-invasive and invasive microdermabrasion want to comfort their skin and return to normal activity as soon as possible. This kit is a holistic regimen that will not only improve a patient's recovery, but also help generate a more positive overall treatment experience."

PhotoMedex' XTRAC Laser Post-Procedure Kit is expected to further strengthen the acceptance and appeal of the company's XTRAC Excimer Laser. XTRAC provides new hope to individuals suffering from psoriasis, vitiligo and other skin conditions. It delivers a carefully focused beam of laser light on psoriasis lesions, delivering high doses necessary for rapid clearing while minimizing exposure of healthy skin to ultraviolet rays.

PhotoMedex XTRAC Laser Post-Procedure Kits are available exclusively from PhotoMedex. For full details including pricing and ordering information, call 1-877-44-XTRAC or email cust@photomedex.com.

About PhotoMedex:

PhotoMedex offers a wide range of products and services across multiple specialty areas, including dermatology, urology, gynecology, orthopedics and other surgical specialties. PhotoMedex is a leader in the development, manufacturing and marketing of medical laser products and services. PhotoMedex also develops and markets products based on its patented, clinically proven Copper Peptide technology for skin health, hair care and wound care. PhotoMedex sells directly to dermatologists, plastic and cosmetic surgeons, spas and salons and through licenses with strategic partners into the consumer market, including a long-term worldwide license agreement with Neutrogena(R), a Johnson & Johnson company. ProCyte brands include Neova(R), Ti-Silc(R), VitalCopper(R), Simple Solutions(R) and AquaSante(R).

In addition, as a result of the recent merger with Photo Therapeutics, PhotoMedex now researches, develops and manufactures non-laser light devices for the treatment of clinical and aesthetic dermatological conditions and adds the Omnilux(tm) products to its arsenal. The Omnilux(tm) products incorporate a new technology based on narrowband Light Emitting Diodes (LEDs) to treat a wide range of dermatological conditions including acne, photodamage, skin rejuvenation, psoriasis, post-surgery wound healing and non-melanoma skin cancer.

Safe Harbor Statement

Some portions of this release, particularly those describing PhotoMedex' strategies contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1993, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While PhotoMedex is working to achieve those goals, actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, including difficulties in marketing its products and services, need for capital, competition from other companies and other factors, any of which could have an adverse effect on the business plans of PhotoMedex, its reputation in the industry or its results. In light of significant uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by PhotoMedex or its subsidiaries that the forward-looking statements will be achieved.

SOURCE: PhotoMedex, Inc.

SSPR 
Belinda Banks 
609/750-9110 
Belinda@sspr.com